Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The role of antiangiogenetic agents in the treatment of breast cancer.
Bareschino MA, Schettino C, Colantuoni G, Rossi E, Rossi A, Maione P, Ciardiello F, Gridelli C. Bareschino MA, et al. Among authors: schettino c. Curr Med Chem. 2011;18(33):5022-32. doi: 10.2174/092986711797636072. Curr Med Chem. 2011. PMID: 22050750 Review.
Erlotinib in cancer treatment.
Bareschino MA, Schettino C, Troiani T, Martinelli E, Morgillo F, Ciardiello F. Bareschino MA, et al. Among authors: schettino c. Ann Oncol. 2007 Jun;18 Suppl 6:vi35-41. doi: 10.1093/annonc/mdm222. Ann Oncol. 2007. PMID: 17591829 Free article. Review.
New avenues for second-line treatment of metastatic non-small-cell lung cancer.
Gridelli C, Maione P, Rossi A, Falanga M, Bareschino M, Schettino C, Colantuoni G, Guerriero C, Nicolella D, Rossi E, Ferrara ML, Palazzolo G. Gridelli C, et al. Among authors: schettino c. Expert Rev Anticancer Ther. 2009 Jan;9(1):115-24. doi: 10.1586/14737140.9.1.115. Expert Rev Anticancer Ther. 2009. PMID: 19105711 Review.
Second and third line treatment in non-small cell lung cancer.
Favaretto A, Pasello G, Magro C, Schettino C, Gridelli C. Favaretto A, et al. Among authors: schettino c. Crit Rev Oncol Hematol. 2009 Aug;71(2):117-26. doi: 10.1016/j.critrevonc.2009.01.009. Epub 2009 Feb 26. Crit Rev Oncol Hematol. 2009. PMID: 19249227 Review.
74 results